MENU

PTPI Stock Petros Pharmaceuticals (PTPI, $0.13) Moving Average Convergence Divergence (MACD) Histogram turned positive on May 13, 2025

A.I.dvisor
at Tickeron.com
Loading...
PTPI - Petros Pharmaceuticals Inc
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $0.1268
Daily change: +$0.0073 (+6.11%)
Daily volume: 7.2M
Capitalization: $271.4K
Industry: Pharmaceuticals: Other
This is a Bullish indicator signaling PTPI's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 46 similar cases where PTPI's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

PTPI's RSI Oscillator stays in oversold zone for 12 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for PTPI just turned positive on May 13, 2025. Looking at past instances where PTPI's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where PTPI advanced for three days, in of 193 cases, the price rose further within the following month. The odds of a continued upward trend are .

PTPI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PTPI as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTPI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PTPI entered a downward trend on May 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.440) is normal, around the industry mean (60.596). P/E Ratio (0.000) is within average values for comparable stocks, (88.278). PTPI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (0.424) is also within normal values, averaging (19.312).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PTPI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTPI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
PTPI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical and diagnostics company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1185 Avenue of the Americas
Phone
+1 973 242-0005
Employees
24
Web
https://www.petrospharma.com